UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Complete androgen blockade for prostate cancer: what went wrong?

The Journal of urology, 2000-07, Vol.164 (1), p.3

2000

Link zum Volltext

Verfügbarkeit prüfen

A prospective study of suramin-induced peripheral neuropathy

Brain (London, England : 1878), 1996-12, Vol.119 (6), p.2039-2052

1996

Link zum Volltext

Verfügbarkeit prüfen

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (8), p.611-621

1993

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2944-2953

1995

Link zum Volltext

Verfügbarkeit prüfen

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer

Seminars in oncology, 1999-10, Vol.26 (5 Suppl 17), p.45

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2174-2186

1995

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2187-2195

1995

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Clinical cancer research, 2001-10, Vol.7 (10), p.3047-3055

2001

Link zum Volltext

Verfügbarkeit prüfen

Acute abdomen in renal transplant recipients. Epidemiology and treatment in not referral transplantation centers

Il Giornale di chirurgia, 2010-11, Vol.31 (11-12), p.497-501

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib

Annals of oncology, 2016-10, Vol.27, p.vi289-vi289

2016

Link zum Volltext

Verfügbarkeit prüfen

Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics

Journal of clinical oncology, 2002-04, Vol.20 (8), p.2171-2180

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical conduct and nursing quality of life in prostate cancer

Hematology/oncology clinics of North America, 2001-06, Vol.15 (3), p.573

2001

Link zum Volltext

Verfügbarkeit prüfen

Ocular Symptoms and Signs Associated With Suramin Sodium Treatment for Metastatic Cancer of the Prostate

American journal of ophthalmology, 1996-03, Vol.121 (3), p.291-296

1996

Link zum Volltext

Verfügbarkeit prüfen

Improvement of potato virus y (PVY) detection and quantitation using PVYN- and PVYO-specific real-time RT-PCR assays

Journal of virological methods, 2006-06, Vol.134 (1-2), p.261-266

2006

Link zum Volltext

Verfügbarkeit prüfen

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer

Urology (Ridgewood, N.J.), 1999-10, Vol.54 (4), p.745-745

1999

Link zum Volltext

Verfügbarkeit prüfen

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

Journal of clinical oncology, 1994-01, Vol.12 (1), p.166-175

1994

Link zum Volltext

Verfügbarkeit prüfen

Correlation between serum PSA and testosterone (T) kinetics in patients (pts) with biochemically relapsed prostate cancer (BRPC) (M0), after local treatment (tx), treated with intermittent androgen deprivation (IAD)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4641-4641

2010

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer

Clinical interventions in aging, 2007-01, Vol.2 (4), p.555-560

Sinibaldi, Victoria J

2007

Link zum Volltext

Verfügbarkeit prüfen

PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.150-150

2011

Link zum Volltext

Verfügbarkeit prüfen

Outcome of octogenarian versus young patients with metastatic renal cell carcinoma, treated with sunitinib

European urology supplements : official journal of the European Association of Urology, 2016-12, Vol.15 (13), p.e1741-e1741

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of sunitinib versus temsirolimus in patients with poor risk metastatic renal cell carcinoma

European urology supplements : official journal of the European Association of Urology, 2016-12, Vol.15 (13), p.e1740-e1740

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin

Cancer epidemiology, biomarkers & prevention, 1998-07, Vol.7 (7), p.631-634

1998

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions

Seminars in oncology, 1996-12, Vol.23 (6 Suppl 14), p.56

1996

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of ketoconazole (K) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Contemporary experience and prognostic indicators

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15007-e15007

2011

Link zum Volltext

Verfügbarkeit prüfen

PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15006-e15006

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Humans
(55)
Life Sciences & Biomedicine
(54)
Male
(41)
Biological And Medical Sciences
(39)
Medical Sciences
(27)
Middle Aged
(27)
Female
(24)
Oncology
(24)
Aged
(22)
Pharmacology. Drug Treatments
(21)
Adult
(18)
Antineoplastic Agents
(17)
Chemotherapy
(16)
Prostatic Neoplasms - Drug Therapy
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Physical Sciences
(13)
Animals
(11)
Urology
(11)
Chemistry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Complete androgen blockade for prostate cancer: what went wrong?

A prospective study of suramin-induced peripheral neuropathy

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule

Acute abdomen in renal transplant recipients. Epidemiology and treatment in not referral transplantation centers

Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib

Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics

Clinical conduct and nursing quality of life in prostate cancer

Ocular Symptoms and Signs Associated With Suramin Sodium Treatment for Metastatic Cancer of the Prostate

Improvement of potato virus y (PVY) detection and quantitation using PVYN- and PVYO-specific real-time RT-PCR assays

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

Correlation between serum PSA and testosterone (T) kinetics in patients (pts) with biochemically relapsed prostate cancer (BRPC) (M0), after local treatment (tx), treated with intermittent androgen deprivation (IAD)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer

PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications

Outcome of octogenarian versus young patients with metastatic renal cell carcinoma, treated with sunitinib

Comparison of sunitinib versus temsirolimus in patients with poor risk metastatic renal cell carcinoma

Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions

Safety and efficacy of ketoconazole (K) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Contemporary experience and prognostic indicators

PSA doubling time (PSADT) and serum testosterone (T) during intermittent androgen deprivation (IAD) in patients with biochemically relapsed prostate cancer (BRCP; M0): Potential predictive implications

Suchergebnisse filtern